T-Curx - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeT-Curx
T-Curx logo

T-Curx

0 followers

About T-Curx

T-CURX is a Biotech company developing personalized immunotherapies on the basis of CAR-T cells, leveraging cutting-edge technologies for targeted and chemotherapy-free cancer treatment.

Recent News

No recent news for this company.

Recent Deals

Key Team Members

Beth Henry

Chief Marketing Officer

Fred Turner

Chief Executive Officer

Isaac Turner

CTO

Tami Wilson-Ciranna

President & CFO

Brandon Charles

Chief Medical Officer

Key Facts

HQ Location

Würzburg, Germany

Founded

2017

Employees

11 - 50

Status

Private

Website

https://t-curx.com